BIRC5 and neoplasm: Escape from SAHA-mediated apoptosis by tumor cells is through upregulation of cyclin A, Ki-67, p53, survivin, and p21 expression; therefore, combination therapies of SAHA with other pharmacological agents that target different pathways may be effective for SAHA-resistant cells.